NXGL vs MCK vs HSIC vs CAH

For growth investors, NEXGEL, Inc.

(NXGL) is the stronger pick with 112. 5% revenue growth year-over-year, versus -1. 9% for Cardinal Health, Inc. (CAH). McKesson Corporation (MCK) offers the better valuation at 19. 2x trailing P/E (16. 7x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, McKesson Corporation (MCK) is the cheapest at 19.

2x versus Cardinal Health, Inc. at 28. 5x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 43x versus Henry Schein, Inc. 's 4. 20x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +270.

4%, compared to -83. 1% for NEXGEL, Inc. (NXGL). Over 10 years, the gap is even starker: MCK returned +339. 0% versus NXGL's -83. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.

02β versus NEXGEL, Inc. 's 0. 85β — meaning NXGL is approximately -5260% more volatile than MCK relative to the S&P 500. On balance sheet safety, NEXGEL, Inc. (NXGL) carries a lower debt/equity ratio of 46% versus 110% for McKesson Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), NEXGEL, Inc.

(NXGL) is pulling ahead at 112. 5% versus -1. 9% for Cardinal Health, Inc. (CAH). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, NXGL leads at 77. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus -37. 8% for NEXGEL, Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus -40. 9% for NXGL. At the gross margin level — before operating expenses — NXGL leads at 31. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 43x versus Henry Schein, Inc. 's 4. 20x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 2x forward P/E versus 17. 1x for Cardinal Health, Inc. — 3. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAH: 38. 0% to $253. 38.

In this comparison, CAH (1.

1% yield), MCK (0. 4% yield) pay a dividend. NXGL, HSIC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 1. 1% yield, +158. 8% 10Y return). Both have compounded well over 10 years (CAH: +158. 8%, NXGL: -83. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NXGL is a small-cap high-growth stock; MCK is a mid-cap quality compounder stock; HSIC is a small-cap quality compounder stock; CAH is a mid-cap quality compounder stock. CAH pays a dividend while NXGL, MCK, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.